Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 27

Results: 10

Rejuvenating Bi(d)ology.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3213, doi. 10.1038/onc.2012.454

By:

Zinkel, S S;
Yin, X M;
Gross, A

Publication type:

Article

miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3306, doi. 10.1038/onc.2012.372

By:

Gebeshuber, C A;
Martinez, J

Publication type:

Article

Bach1 is critical for the transformation of mouse embryonic fibroblasts by Ras<sup>V12</sup> and maintains ERK signaling.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3231, doi. 10.1038/onc.2012.336

By:

Nakanome, A;
Brydun, A;
Matsumoto, M;
Ota, K;
Funayama, R;
Nakayama, K;
Ono, M;
Shiga, K;
Kobayashi, T;
Igarashi, K

Publication type:

Article

Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3286, doi. 10.1038/onc.2012.334

By:

Dong, P;
Karaayvaz, M;
Jia, N;
Kaneuchi, M;
Hamada, J;
Watari, H;
Sudo, S;
Ju, J;
Sakuragi, N

Publication type:

Article

Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3220, doi. 10.1038/onc.2012.340

By:

Ben-Shmuel, A;
Shvab, A;
Gavert, N;
Brabletz, T;
Ben-Ze'ev, A

Publication type:

Article

HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3296, doi. 10.1038/onc.2013.150

By:

Qiu, X;
Dong, S;
Qiao, F;
Lu, S;
Song, Y;
Lao, Y;
Li, Y;
Zeng, T;
Hu, J;
Zhang, L;
Fan, H

Publication type:

Article

Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3274, doi. 10.1038/onc.2012.335

By:

Razandi, M;
Pedram, A;
Jordan, V C;
Fuqua, S;
Levin, E R

Publication type:

Article

RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3263, doi. 10.1038/onc.2012.337

By:

Abhari, B A;
Cristofanon, S;
Kappler, R;
von Schweinitz, D;
Humphreys, R;
Fulda, S

Publication type:

Article

Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3246, doi. 10.1038/onc.2012.351

By:

Aprelikova, O;
Palla, J;
Hibler, B;
Yu, X;
Greer, Y E;
Yi, M;
Stephens, R;
Maxwell, G L;
Jazaeri, A;
Risinger, J I;
Rubin, J S;
Niederhuber, J

Publication type:

Article

The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling.

Published in:

Oncogene, 2013, v. 32, n. 27, p. 3254, doi. 10.1038/onc.2012.338

By:

Sully, K;
Akinduro, O;
Philpott, M P;
Naeem, A S;
Harwood, C A;
Reeve, V E;
O'Shaughnessy, R F;
Byrne, C

Publication type:

Article